New in CME courses – Optimizing Glycemic Control: A Continuing Quality Improvement Program for Primary Care

Topic: Endocrinology

Target Audience: Primary Care Clinicians

The Family Medicine Associates wrap up their Quality Improvement program on the management of Type 2 Diabetes.

By the end of the course, participants will be able to:

  1. Outline the benefits, indications, and role of continuous glucose monitoring (CGM) in optimizing glycemic control in patients with T2DM
  2. Describe the clinical and pharmacokinetic/pharmacodynamic (PK/PD) differences between ultralong-acting and conventional basal insulins
  3. Incorporate newer basal insulins to optimize diabetes therapy and achieve A1C goals

This activity – Optimizing Glycemic Control: A Continuing Quality Improvement Program for Primary Care, offers 1.0 AMA PRA Category 1 Credit™.

Click here to start this activity!

If you haven’t taken the other parts of this course yet, you can get to them here:

Achieving Glycemic Control in Type 2 Diabetes – A Quality Improvement Program for Primary Care

Offering 1 AMA PRA Category 1 Credit Click here to start

Optimizing Control in T2D: Part 2 in a Quality Improvement Program for Primary Care

Offering 1 AMA PRA Category 1 CreditClick here to start